Stocks TelegraphStocks Telegraph
Stock Ideas

BDTX Stock Performance and Key Statistics

NASDAQ : BDTX

Black Diamond Therapeutics

$2.03
0.05+2.53%
At Close 4:00 PM
63.99
BESG ScoreESG Rating

stock performance chart

BDTX Fundamental Analysis

Based on recent data, Black Diamond Therapeutics, Inc. (BDTX) shows an Average True Range (ATR) of 0.14 and an Enterprise Value of 230.77M. Its average trading volume over the past 3 months is 1.09M, indicating liquidity. These fundamental metrics provide insight into BDTX's underlying financial health and market activity.

ATR0.14
Enterprise Value230.77M
Avg Vol (3 Months)1.09M
Avg Vol (10 Days)509.63K

BDTX Technical Analysis Indicators

Black Diamond Therapeutics, Inc. (BDTX) technical indicators as of September 15, 2026: the SMA 20 is 5.7%, SMA 50 at -0.31%, and SMA 200 at -14.58%. The RSI 14 value is 53.12, suggesting its current momentum. These technical analysis signals help assess BDTX's price trends and potential future movements.

SMA 205.7%
SMA 50-0.31%
SMA 200-14.58%
RSI 1453.12

BDTX Stock Performance Overview

Black Diamond Therapeutics, Inc. (BDTX) stock performance overview as of September 15, 2026: The 52-week high is $4.94 (currently -49.39% below), and the 52-week low is $1.6 (currently 109.21% above). Over the past year, BDTX's performance is 8.6%, compared to the S&P 500's 0.31% change.

52-Week High4.94
52-Week High Chg-49.39%
52-Week Low1.6
52-Week Low Chg+109.21%
S&P 500 52-Week Chg0.31%

Black Diamond Therapeutics, Inc. (BDTX) Historical Stock Performance

According to market data, Black Diamond Therapeutics, Inc. (BDTX) stock's recent performance metrics show that over the last month, BDTX is -7.34%, with a Year-to-Date (YTD) performance of -1.23%. Over the past year, the stock has seen a 8.6% change. These figures summarize BDTX's price movements across various periods, reflecting its historical returns.

Period1 Week1 MonthQuarterHalf Year1 YearYTD
High2.152.322.323.974.943.97
Low1.921.921.61.61.61.6
Performance-9.09%-7.34%-40.15%-23.81%+8.60%-1.23%

Industry Analysis and Valuation

According to current financial data, BDTX stock's P/E (TTM) ratio is -2.74, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.25. Key valuation ratios for BDTX, including P/S (N/A), P/B (1.21), and P/FCF (-3.63), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.

ValuationBDTXSector MedianIndustry AvgS&P 500
P/E (TTM)-2.74-1.25-194.3832.59
P/S (TTM)N/A3.74467.585.98
P/B (TTM)1.211.1815.575.6
P/FCF (TTM)-3.63-2.24-700.3328.75

Frequently Asked Questions

How is BDTX price-to-earnings ratio currently?
BDTX has a current P/E ratio of -2.74
How are BDTX's price-to-sale and price-to-book ratios?
The BDTX stock has a trailing twelve month price-to sales (P/S) ratio of N/A while its price-to-book (P/B) value is 1.21.
Is Black Diamond Therapeutics, Inc.'s price-to-cashflow ratio high or low?
BDTX's price-to-free-cashflow (P/FCF) ratio is -3.63, an indicator that is currently being trending upward.
What's current simple moving average (SMA) for BDTX?
Based on BDTX's recent bid, its distance from 20 days simple moving average is 5.7%. It is -0.31% apart from 50 days simple moving average, and it is -14.58% apart from 200 days simple moving average.
What is the 52-week price range for BDTX?
The 52-week high for BDTX is $4.94 which is -49.39% away from the current price level whereas the distance of that from the 52-week low of $1.60 stands at 109.21%.
An overview of BDTX's stock performance: how did it fare?
The performance of BDTX stock was not encouraging with most of its significant price indicators in red. Black Diamond Therapeutics, Inc.(NASDAQ: BDTX) shares have moved upward +2.53% or $0.05 in the latest trading session and have lost -1.23% year-to-date (YTD). The stock has gained nearly 8.6% over the past year. After moving -40.15% over the trailing 3-month period, the stock is -23.81% lower in the 6-month period. Looking at its performance over the shorter term, it'slost -9.09% a week and -7.34% a month.
What is BDTX's 14-day relative strength index (RSI)?
The current 14-day RSI for BDTX stock is 53.12. Investors and traders alike rely on the relative strength index, or RSI, as an oscillating indicator. In terms of values, the RSI operates within a range ranging from 0 to 100. A rising RSI line indicates strength in the shares. As the RSI line falls, the opposite occurs. It is possible to examine different time periods when using the RSI indicator. Shorter time frames can cause the RSI to be more volatile. Most traders pay close attention to the marks between 30 and 70 on the RSI scale. When the stock price moves over 70, it is often considered to be an indicator of overbought conditions. Dropping below 30 indicates oversold territory. These levels are often used by traders to forecast stock price reversals.
For BDTX, what is the average true range (ATR) for the past two weeks?
ATR stands for Average True Range, which may be useful when traders or investors are assessing technical inventory. Currently, Black Diamond Therapeutics, Inc. (BDTX) has a 14-day ATR of 0.14.
What is BDTX's current enterprise value?
After closing at $1.98 with 57.3M of its shares outstanding, the current enterprise value of BDTX is roughly 230.77M.
Over the past year, how has the stock price of BDTX changed?
Black Diamond Therapeutics, Inc. (NASDAQ: BDTX) is up 8.6% when it comes to the percentage price change over the past 52-weeks. The percentage price change came more than that of broader S&P 500 index that came at a rise of 0.31%. BDTX stock price is also down -1.23% on its value in year-to-date trading.
What is the average trading volume for BDTX shares?
The number outstanding shares of BDTX is 57.3M, and of these 68.91% shares are freely available for trading. On average, BDTX stock has traded 509.63K shares per day for the past 10 days. A total of 514.13K shares changed hands during the last trading session with the average session volume of 1.1M shares.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph